Ignite Creation Date:
2024-05-06 @ 6:22 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05639114
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2022-11-04
Brief Title:
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus SIRIUS-SLE 1
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis